Skip to content

Ionis Pharmaceuticals

US · IONS #1749 by market cap Listed 1970
26.58 -0.64 -2.35%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:59

Quant vs Street three independent views, side by side

StockVane factor grade
D+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: BMO Capital moved from Hold to Buy on 2026-10-21.

Analyst consensus 19 analysts

Buy
Avg price target 72.39 +172.3%
Price target rangecurrent 26.58
Low41.00
Avg72.39
High100.00
Buy 95% Hold 5% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-11 Barclays -- Buy 70.00
2026-11-10 TD Cowen -- Buy 53.00
2026-11-10 CCORF -- Buy 72.00
2026-11-10 Wells Fargo -- Buy 80.00
2026-11-10 Morgan Stanley -- Buy 75.00
2026-11-10 BMO Capital -- Buy 66.00
2026-11-10 H.C. Wainwright -- Buy 70.00
2026-11-10 Barclays -- Buy 85.00
2026-11-10 Oppenheimer -- Buy 70.00
2026-11-09 Wells Fargo -- Buy 80.00
2026-11-09 UBS -- Buy 81.00
2026-11-09 Piper Sandler -- Buy 87.00
2026-11-09 BofA Securities -- Buy 63.00
2026-11-09 Citi -- Buy 100.00
2026-11-09 Goldman Sachs -- Hold 41.00
2026-11-09 H.C. Wainwright -- Buy 100.00
2026-11-09 RBC Capital -- Buy 60.00
2026-11-02 BMO Capital -- Buy 66.00
2026-10-28 CCORF -- Buy 85.00
2026-10-28 Citi -- Buy 100.00
2026-10-26 H.C. Wainwright -- Buy 100.00
2026-10-21 Piper Sandler -- Buy 87.00
2026-10-21 Morgan Stanley -- Buy 104.00
2026-10-21 BMO Capital -- Buy 66.00
2026-10-21 Citi -- Buy 100.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-10-21 BMO Capital Hold → Buy 66.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-09 -- ±11.65% -21.36% (beat)
2026/Q2 2026-07-29 -- ±8.18% -2.28% (in line)
2026/Q1 2026-04-29 -- ±5.49% +4.25% (in line)
2025/Q4 2026-02-25 -- ±9.19% -5.29% (in line)
2025/Q3 2025-10-29 -- ±10.87% -2.30% (in line)
2025/Q2 2025-07-30 -- ±10.68% +4.56% (in line)
2025/Q1 2025-04-30 -- ±12.79% +3.02% (in line)
2024/Q4 2025-02-19 -- ±9.94% -0.44% (in line)
2024/Q3 2024-11-06 -- ±7.14% +0.62% (in line)
2024/Q2 2024-08-01 -- ±7.19% +3.76% (in line)
2024/Q1 2024-05-07 -- ±6.67% -3.19% (in line)
2023/Q4 2024-02-21 -- ±10.24% -1.85% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:59:29 · For reference only, not investment advice and not tailored to your situation.

Ionis Pharmaceuticals discussion 0 comments

Add a comment